On June 20, 2024, Regeneron Pharmaceuticals, Inc announced that it held its annual general meeting on June 14, 2024, and declared voting results. Accordingly, the shareholder proposal submitted by John Chevedden requesting simple majority voting requirements was approved.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,048 USD | -1.97% | +0.51% | +19.52% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.52% | 115B | |
+16.34% | 122B | |
+21.22% | 26.64B | |
-23.71% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-18.17% | 15.49B | |
+64.42% | 14.83B | |
+2.14% | 13.67B | |
+120.04% | 11.12B |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.
- Declaration of Voting Results by Regeneron Pharmaceuticals, Inc